Literature DB >> 2838386

Mapping and sequencing of the dihydrofolate reductase gene (DFR1) of Saccharomyces cerevisiae.

B J Barclay1, T Huang, M G Nagel, V L Misener, J C Game, G M Wahl.   

Abstract

The dihydrofolate reductase gene (DFR1) from Saccharomyces cerevisiae has been mapped and sequenced. The gene was isolated on an 8.8-kb BamHI fragment from a yeast genomic library by screening of Escherichia coli transformants for resistance to trimethoprim. A 1.8-kb SalI-BamHI fragment which was able to confer methotrexate resistance in yeast also complemented an E. coli DHFR-deficient (folA) mutant. Nucleotide sequence analysis revealed that the yeast DFR1 gene encoded a polypeptide with a predicted Mr of 24230. The deduced sequence of 211 amino acid residues showed considerable homology with DHFRs from both bacterial and animal sources. The codon bias index of the DFR1 coding region is 0.0083, which indicates a random pattern of codon usage. The upstream region contains two consensus sequences required for binding of the yeast's positive regulatory factor, GCN4, suggesting that the DFR1 gene might be subject to the amino acid general control. Several potential 'TATA' boxes are located in the sequence 5' to the gene. Located in the 3' flanking region are homologies with several canonical sequences thought to be required for efficient transcription termination in yeast. We also mapped the DFR1 gene to a position 1.4 cM proximal to the MET7 locus on chromosome XV.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2838386     DOI: 10.1016/0378-1119(88)90523-9

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  7 in total

1.  Genetic characterization of trimethoprim resistance in Haemophilus influenzae.

Authors:  R de Groot; M Sluijter; A de Bruyn; J Campos; W H Goessens; A L Smith; P W Hermans
Journal:  Antimicrob Agents Chemother       Date:  1996-09       Impact factor: 5.191

2.  DNA sequence and comparative genomics of pAPEC-O2-R, an avian pathogenic Escherichia coli transmissible R plasmid.

Authors:  Timothy J Johnson; Kylie E Siek; Sara J Johnson; Lisa K Nolan
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

3.  In vitro generation of novel pyrimethamine resistance mutations in the Toxoplasma gondii dihydrofolate reductase.

Authors:  M G Reynolds; J Oh; D S Roos
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

4.  Isolation and expression of the Pneumocystis carinii dihydrofolate reductase gene.

Authors:  J C Edman; U Edman; M Cao; B Lundgren; J A Kovacs; D V Santi
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

5.  Characterization of the Saccharomyces cerevisiae Fol1 protein: starvation for C1 carrier induces pseudohyphal growth.

Authors:  Ulrich Güldener; Gabriele J Koehler; Christoph Haussmann; Adelbert Bacher; Jörn Kricke; Dietmar Becher; Johannes H Hegemann
Journal:  Mol Biol Cell       Date:  2004-05-28       Impact factor: 4.138

6.  Reverse Chemical Genetics: Comprehensive Fitness Profiling Reveals the Spectrum of Drug Target Interactions.

Authors:  Lai H Wong; Sunita Sinha; Julien R Bergeron; Joseph C Mellor; Guri Giaever; Patrick Flaherty; Corey Nislow
Journal:  PLoS Genet       Date:  2016-09-02       Impact factor: 5.917

7.  Genome-Wide Screen Reveals sec21 Mutants of Saccharomyces cerevisiae Are Methotrexate-Resistant.

Authors:  Lai H Wong; Stephane Flibotte; Sunita Sinha; Jennifer Chiang; Guri Giaever; Corey Nislow
Journal:  G3 (Bethesda)       Date:  2017-04-03       Impact factor: 3.154

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.